One year in review 2021: fibromyalgia
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Fibromyalgia (FM) is a syndrome of unknown aetiology characterised by chronic pain, fatigue, and disturbed sleep. This review presents and summarises the 2020 literature on FM by retrieving all articles indexed in PubMed between 1 January 2020 and 31 December 2020. The attention of the scientific community towards FM is constantly growing, and this year's review is focused on the diagnostic, pathogenetic and therapeutic aspects of this syndrome. In particular, the treatment options for FM, both pharmacological and non-pharmacological, have been extensively studied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Wolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20140 · Cited by 3,952 · cited 1×
“In 2010, the ACR preliminary diagnostic criteria (ACR 2010 Cr) (9) eliminated the need for eliciting tender points (TPs) and introduced the Widespread Pain Index (WPI), and the Symptom Severity Scale (SSS) to measure the manifold associated symptoms.”
BackgroundBaer, R. A., Smith, G. T., Lykins, E., Button, D., Krietemeyer, J., Sauer, S., Walsh, E., Duggan, D., & Williams, J. M. G. (2008) · Assessment · doi:10.1177/1073191107313003 · Cited by 2,930
2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria
Wolfe, F., Clauw, D. J., Fitzcharles, M.-A., Goldenberg, D. L., Häuser, W., Katz, R. L., Mease, P. J., Russell, A. S., Russell, I. J., & Walitt, B. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.08.012 · Cited by 2,232 · cited 1×
“A further revision (ACR 2016 Cr) (11) added the generalised pain criterion (pain in at least four of five regions), specified somatic symptoms including headache, pain or abdominal cramps, and depression, also stating that a diagnosis of FM does not exclude the presence of other diagnoses.”
BackgroundWOLFE, F., CLAUW, D. J., FITZCHARLES, M.-A., GOLDENBERG, D. L., HÄUSER, W., KATZ, R. S., MEASE, P., RUSSELL, A. S., RUSSELL, I. J., & WINFIELD, J. B. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100594 · Cited by 1,499
Nabilone for the treatment of pain in fibromyalgia.
Skrabek, R. Q., Galimova, L., Ethans, K., & Perry, D. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.002 · Cited by 384 · cited 1×
“In 2008, a randomised double-blind placebo-controlled study evaluated the effectiveness of nabilone, a cannabinoid commercialised in the United States, in 20 patients with FM (43).”
BackgroundThe Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Ware, M. A., Fitzcharles, M.-A., Joseph, L., & Shir, Y. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c76f70 · Cited by 324 · cited 1×
“pared nabilone to amitriptyline (10 mg) in treating insomnia in FM patients, finding no significant improvement in pain, mood, or quality of life in the nabilone group (44).”
BackgroundDiagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives
Galvez-Sánchez, C. M., & Reyes del Paso, G. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041219 · Cited by 241 · cited 1×
“(13) critically reviewed of the ACR Diagnostic Criteria for FM and pointed out a series of limitations of the ACR criteria from 2010 to 2016, in particular the persistence of a considerable FM misdiagnosis rate in the general population and the lack of sufficient recognition of psychological, environmental, and socioc…”
BackgroundNutritional Interventions in the Management of Fibromyalgia Syndrome
Pagliai, G., Giangrandi, I., Dinu, M., Sofi, F., & Colombini, B. (2020) · Nutrients · doi:10.3390/nu12092525 · Cited by 113
Clinical and anti-aging effect of mud-bathing therapy for patients with fibromyalgia
Maeda, T., Kudo, Y., Horiuchi, T., & Makino, N. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3233-4 · Cited by 24
Cited by
Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
Sarzi-Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00506-w · Cited by 793
Self-citationLong-COVID in children and adolescents: a systematic review and meta-analyses
Lopez-Leon, S., Wegman-Ostrosky, T., Ayuzo del Valle, N. C., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-13495-5 · Cited by 528
Alexithymia and Psychological Distress in Patients with Fibromyalgia and Rheumatic Disease
Marchi, L., Marzetti, F., Orrù, G., Lemmetti, S., Miccoli, M., Ciacchini, R., Hitchcott, P. K., Bazzicchi, L., Gemignani, A., & Conversano, C. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01735 · Cited by 72
Physical and mental impact of COVID-19 outbreak on fibromyalgia patients
Aloush, V., Gurfinkel, A., Shachar, N., Ablin, J. N., & Elkana, O. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/rxk6s4 · Cited by 45
Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis
Migliorini, F., Maffulli, N., Eschweiler, J., Baroncini, A., Bell, A., & Colarossi, G. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-03995-z · Cited by 40
Metadata
- Authors
- Alciati, A., Nucera, V., Masala, I. F., Giallanza, M., La Corte, L., Giorgi, V., Sarzi-Puttini, P., & Atzeni, F.
- Venue
- Clinical and Experimental Rheumatology
- Published
- 2021-06-21
- Volume
- 39
- Issue
- 3
- Pages
- 3-12
- ISSN
- 0392-856X (ISSN-L)
- 1593-098X
- OpenAlex
- W2990379271
- Cited by
- 200
- References
- 11
- FWCI
- 24.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: One year in review 2021: fibromyalgia. https://app.cochat.ai/papers/10.55563/clinexprheumatol/gz4i3i
- The paper
- Alciati, A., Nucera, V., Masala, I. F., Giallanza, M., La Corte, L., Giorgi, V., Sarzi-Puttini, P., & Atzeni, F. (2021). One year in review 2021: fibromyalgia. Clinical and Experimental Rheumatology. https://doi.org/10.55563/clinexprheumatol/gz4i3i
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.